Increased numbers of circulating ECs are associated with systemic GVHD

International Journal of Laboratory Hematology

Volumn 33, Issue 5, 2011, Pages 507-515

  Yan, Z ^a   Zeng, L ^a   Jia, L ^a   Xu, S ^a   Ding, S ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acute graft versus host disease; Endothelial cell; Endothelial injury

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T CELL DEPLETION; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; WHOLE BODY RADIATION;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; ENDOTHELIAL CELLS; FEMALE; GRAFT VS HOST DISEASE; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 80051918483     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01322.x     Document Type: Article

References (32)

1. Bearman S.I. (1995) The ayndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 85, 3005-3020.
2. Boos C.J., Lip G.Y. & Blann A.D. (2006) Circulating endothelial cells in cardiovascular disease. Journal of the American College of Cardiology 48, 1538-1547.
3. Boos C.J., Lane D.A., Karpha M., Beevers D.G., Haynes R. & Lip G.Y. (2007) Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest 132, 1540-1547.
4. Borawski J., Naumnik B. & Mysliwiec M. (2002) Increased soluble thrombomodulin does not always indicate endothelial injury. Clinical and Applied Thrombosis/Hemostasis 8, 87-89.
5. Cesarone M.R., Belcaro G., Pellegrini L., Ledda A., Vinciguerra G., Ricci A., Gizzi G., Ippolito E., Fano F., Dugall M., Acerbi G., Cacchio M., Di Renzo A., Hosoi M., Stuard S. & Corsi M. (2006) Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton. Journal of Cardiovascular Pharmacology and Therapeutics 11, 93-99.
6. Combes V., Simon A.C., Grau G.E., Arnoux D., Camoin L., Sabatier F., Mutin M., Sanmarco M., Sampol J. & Dignat-George F. (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. Journal of Clinical Investigation 104, 93-102.
7. Davis R.E. & Smoller B.R. (1992) T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs. American Journal of Pathology 141, 691-698.
8. Dumler J.S., Beschorner W.E., Farmer E.R., Di Gennaro K.A., Saral R. & Santos G.W. (1989) Endothelial-cell injury in cutaneous acute graft-versus-host disease. American Journal of Pathology 135, 1097-1103.
9. Ertault-Daneshpouy M., Leboeuf C., Lemann M., Bouhidel F., Ades L., Gluckman E., Socié G. & Janin A. (2004) Hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood 103, 4681-4684.
10. Ferrara J.L. & Deeg H.J. (1991) Graft-versus-host disease. New England Journal of Medicine 324, 667-674.
11. Freestone B., Chong A.Y., Nuttall S., Blann A.D. & Lip G.Y. (2007) Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Chest 132, 1253-1258.
12. Galley H.F. & Webster N.R. (2004) Physiology of the endothelium. British Journal of Anaesthesia 93, 105-113.
13. Grabie N., Gotsman I., DaCosta R., Pang H., Stavrakis G., Butte M.J., Keir M.E., Freeman G.J., Sharpe A.H. & Lichtman A.H. (2007) Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell-mediated injury in the heart. Circulation 116, 2062-2071.
14. Ichiba T., Teshima T., Kuick R., Misek D.E., Liu C., Takada Y., Maeda Y., Reddy P., Williams D.L., Hanash S.M. & Ferrara J.L. (2003) Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 102, 763-771.
15. Kaplan D.H., Anderson B.E., McNiff J.M., Jain D., Shlomchik M.J. & Shlomchik W.D. (2004) Target antigens determine graft-versus-host disease phenotype. The Journal of Immunology 173, 5467-5475.
16. Lu S.X., Holland A.M., Na I.-K., Terwey T.H., Alpdogan O., Bautista J.L., Smith O.M., Suh D., King C., Kochman A., Hubbard V.M., Rao U.K., Yim N., Liu C., Laga A.C., Murphy G., Jenq R.R., Zakrzewski J.L., Penack O., Dykstra L., Bampoe K., Perez L., Furie B., Furie B. & van den Brink M.R.M. (2010) Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease. The Journal of Immunology, 2010, 185.
17. Nash R.A., Piñeiro L.A., Storb R., Deeg H.J., Fitzsimmons W.E., Furlong T., Hansen J.A., Gooley T., Maher R.M., Martin P., McSweeney P.A., Sullivan K.M., Anasetti C. & Fay J.W. (1996) FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors. Blood 88, 3634-3641.
18. Nash R.A., Antin J.H., Karanes C., Fay J.W., Avalos B.R., Yeager A.M., Przepiorka D., Davies S., Petersen F.B., Bartels P., Buell D., Fitzsimmons W., Anasetti C., Storb R. & Ratanatharathorn V. (2000) Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96, 2062-2068.
19. Paczesny S., Krijanovski O.I., Braun T.M., Choi S.W., Clouthier S.G., Kuick R., Misek D.E., Cooke K.R., Kitko C.L., Weyand A., Bickley D., Jones D., Whitfield J., Reddy P., Levine J.E., Hanash S.M. & Ferrara J.L. (2009) A biomarker panel for acute graft-versus-host disease. Blood 113, 273-278.
20. Penack O., Henke E., Suh D., King C.G., Smith O.M., Na I.-K., Holland A.M., Ghosh A., Lu S.X., Jenq R.R., Liu C., Murphy G.F., Lu T.T., May C., Scheinberg D., Gao D.C., Mittal V., Heller G., Benezra R., Marcel R. & van den Brink M. (2010) Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. Journal of the National Cancer Institute 102, 894-908.
21. Pettitt A.R. & Clark R.E. (1994) Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplantation 14, 495-504.
22. Przepiorka D., Weisdorf D., Martin P., Klingemann H.G., Beatty P., Hows J. & Thomas E.D. (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplantation 15, 825-828.
23. Richardson P. & Guinan E. (2001) Hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Acta Haematologica 106, 57-68.
24. Rothermel A.L., Wang Y., Schechner J., Mook-Kanamori B., Aird W.C., Pober J.S., Tellides G. & Johnson D.R. (2004) Endothelial cells present antigens in vivo. BMC Immunology, 16, 5.
25. Sackstein R., Messina J.L. & Elfenbein G.J. (2003) In vitro adherence of lymphocytes to dermal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD. Blood 101, 771-778.
26. Sari I., Okan T., Akar S., Cece H., Altay C., Secil M., Birlik M., Onen F. & Akkoc N. (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology 45, 283-286.
27. Smadja D.M., Gaussem P., Mauge L., Israël-Biet D., Dignat-George F., Peyrard S., Agnoletti G., Vouhé P.R., Bonnet D. & Lévy M. (2009) Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 119, 374-381.
28. Stelljes M., Hermann S., Albring J., Köhler G., Löffler M., Franzius C., Poremba C., Schlösser V., Volkmann S., Opitz C., Bremer C., Kucharzik T., Silling G., Schober O., Berdel W.E., Schäfers M. & Kienast J. (2009) Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography. Blood 111, 2909-2918.
29. Tsuchiyama J., Yoshino T., Saito T., Furukawa T., Ito K., Fuse I. & Aizawa Y. (2009) Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractions. Bone Marrow Transplantation 11, 863-873.
30. Woywodt A., Scheer J., Hambach L., Buchholz S., Ganser A., Haller H., Hertenstein B. & Haubitz M. (2004) Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem-cell transplantation. Blood 10, 3479-3494.
31. Zeng L., Yan Z., Ding S., Xu K. & Wang L. (2008a) Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice. Transplantation Proceedings. 40, 2670-2673.
32. Zeng L., Yan Z., Wang L., Du B., Pan X. & Xu K. (2008b) Irradiation is an early determinant of endothelial injury during hematopoietic stem cell transplantation. Transplantation Proceedings. 40, 2661-2664.